Shop
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 21 2024
The protective association between dietary flavonoid intake and the risk of dementia has been the focus of yet another study; this one being published...
Researchers wishing to evaluate the safety profile and characterize the immunologic effects of high dose vs low dose cholecalciferol (vitamin D3) supplementation in patients with MS, conducted a double-blind, randomized study of 40 patients with relapsing-remitting MS. Patients received 10,400 IU or 800 IU of D3 daily for 6 months. Assessments were conducted at baseline, 3 and 6 months. Results showed a mean increase of 25(OH)D levels was greater in the high dose group vs the low dose group. In the high dose group only, they found a reduction in the proportion of interleukin-17+CD4+ T cells, CD161+CD4+ T cells, and effector memory CD4+ T cells with concomitant increase in central memory CD4+ T cells and naïve CD4+ T cells. In other words, as the levels of vitamin D increased, there was a corresponding decrease in the levels of CD4+ T cells and interleukin-17, a protein they create which is pro-inflammatory. The researchers concluded that vitamin D3 supplementation with 10,400 IU daily is safe and tolerable in patients with MS and exhibits in vivo pleiotropic immunomodulatory effects in MS.
Sotirchos ES, et al. Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis. Neurology. 2015
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment